Clinical trial
A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease
NCT00443417 · SK Chemicals Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00443417 |
|---|---|
| Title | A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease |
| Official title | Dose Finding Study to Assess the Efficacy and Safety of SK-PC-B70M in Patients With Mild to Moderate Alzheimer's Disease |
| Lead sponsor | SK Chemicals Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | SK-PC-B70M |
| Enrollment | 188 |
| Start date | Apr 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Mar 6, 2007 |
| Last update posted | Dec 9, 2009 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: